$0.43
+0.04 (+10.10%)
Open$0.40
Previous Close$0.39
Day High$0.44
Day Low$0.38
52W High$32.88
52W Low$24.50
Volume—
Avg Volume243.1K
Market Cap31.56M
P/E Ratio—
EPS$-0.58
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+7,999.7% upside
Current
$0.43
$0.43
Target
$34.78
$34.78
$27.07
$34.78 avg
$51.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.04M | 5.83M | 5.25M |
| Net Income | -1,403,193 | -1,267,217 | -1,265,078 |
| Profit Margin | -23.2% | -21.7% | -24.1% |
| EBITDA | -1,857,435 | -1,820,131 | -1,644,658 |
| Free Cash Flow | -1,644,650 | -1,133,887 | -1,157,439 |
| Rev Growth | +22.3% | +8.5% | -2.3% |
| Debt/Equity | 0.94 | 0.66 | 0.85 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |